bioAffinity Technologies
BIAF
BIAF
9 hedge funds and large institutions have $92.5K invested in bioAffinity Technologies in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
89% less capital invested
Capital invested by funds: $824K → $92.5K (-$731K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$60.6K | |
| 2 | +$25.3K | |
| 3 | +$23.2K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$22.2K |
| 5 |
Citigroup
New York
|
+$15.3K |
Top Sellers
| 1 | -$719K | |
| 2 | -$49.8K | |
| 3 | -$49.1K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$30.9K |
| 5 |
AF
Allworth Financial
Folsom,
California
|
-$5.3K |
